Block listing Interim Review

Summary by AI ^BETAClose X

Bellevue Healthcare Trust PLC reports a block listing six-monthly return for the period from March 21, 2025, to September 22, 2025, concerning their BBH Block Schemes. The balance of unallotted securities from the previous return totaled 47,478,761 ordinary shares of 1p each, comprised of 6,787,416 shares under the 2019 (iii) scheme and 40,691,345 shares under the 2022 (i) scheme. There was no increase to the block schemes and no securities were issued or allotted during this period. Consequently, the balance of shares not yet issued or allotted at the end of the period remains at 47,478,761 ordinary shares.

Disclaimer*

Bellevue Healthcare Trust PLC

23 September 2025

BELLEVUE HEALTHCARE TRUST PLC

LEI: 213800HQ3J3H9YF2UI82

BLOCK LISTING SIX MONTHLY RETURN

Name of applicant:		Bellevue Healthcare Trust plc
Name of scheme:		BBH Block Schemes a) 2019 (iii) b) 2019 (iv) c) 2021 (i) d) 2021 (ii) e) 2022 (i)
Period of return:	From:	21 March 2025	To:	22 September 2025
Balance of unallotted securities under scheme(s) from previous return:		a) 6,787,416 b) 0 c) 0 d) 0 e) 40,691,345 Total: 47,478,761 ordinary shares of 1p each ("Ordinary Shares")
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		a) 0 b) 0 c) 0 d) 0 e) 0
Less: Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G):		a) 0 b) 0 c) 0 d) 0 e) 0
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		a) 6,787,416 b) 0 c) 0 d) 0 e) 40,691,345 Total: 47,478,761 Ordinary Shares

Name of contact:

NSM Funds (UK) Limited

Telephone number of contact:

020 3697 5770

Bellevue@nsm.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END